Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers

Summary

The purpose of the study is to determine if DSC127 is effective in increasing incidence of complete wound closure at 10 weeks confirmed at a visit 2 weeks later when compared to the vehicle (gel without active ingredient) in subjects with diabetes mellitus (DM) who have chronic Wagner Grade 1 or 2 plantar neuropathic foot ulcers, 0.75 - 6 cm2 in size.

Timeline

Start

2013-02

Primary completion

2015-12

Completion

2015-12

Drugs

Indications